reference/1969987

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1969987

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	148
issn	2372-7705
pageRange	137-148
publicationName	Molecular Therapy - Oncolytics
startingPage	137
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b3971a2830f3f2919843c8207a0cba3e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Wei L, Yang Y, Gupta P, Wang A, Zhao M, Zhao Y, Qu M, Ke Y, Liu Y, Liu H, Xu X, Sun Y, Chen Z, Hu Z. A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway. Molecular Therapy - Oncolytics. 2020 Sep;18():137–48. doi: 10.1016/j.omto.2020.06.008.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_498324900c68c774be77901d13cf91e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8289-097X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcba72673f2fd5783b292659d4c02d82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61d394970ee3d2984d244a49205ccc23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ae014e357bf0f97737849baba6765f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6214bc0c2bea2b928ef50dde0240213d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bfc57f2b9a9976de27f29f54290d881 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f981c0775e20c792ce8ad942ce12466 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5acbb91f41401c89bade78ecef9ccbca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c0194f9b943a85de0e32929c672aad1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c85f1d3a657de4bc7dd73af1f8df5817 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05ab68ca78593ddde66f67749c4fc56b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bede690153577ce5538ef92f01ca4145 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12e58daf38cecd5f597997569031a14a
date	2020-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/j.omto.2020.06.008 https://pubmed.ncbi.nlm.nih.gov/PMC7341061 https://pubmed.ncbi.nlm.nih.gov/32671189
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/44296 https://portal.issn.org/resource/ISSN/2372-7705
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727

Total number of triples: 38.